FIELD: pharmacology.
SUBSTANCE: invention is a pharmaceutical composition containing a substance of formula (I)
,
or a pharmaceutically acceptable salt thereof and a lubricant other than a metal salt, as well as a method to obtain a preparation of this pharmaceutical composition.
EFFECT: invention allows to improve the stability of a pharmaceutical composition containing an amide derivative of formula (I) and to increase the shelf life without qualitative changes over time.
17 cl, 4 dwg, 9 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN | 2005 |
|
RU2440112C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2011 |
|
RU2575829C2 |
| STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2013 |
|
RU2614382C2 |
| PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
| ABIRATERONE ACETATE FORMULATION | 2014 |
|
RU2732136C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS BASED ON PRODUCTS CONTAINING LIPASES, FIRST OF ALL PANCREATINE, AND SURFACTANTS | 2005 |
|
RU2381813C2 |
| ENCAPSULATED DOSAGE FORM, CONTAINING MONTELUKAST AND LEVOCETIRIZINE | 2012 |
|
RU2606857C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING FENOSANIC ACID | 2019 |
|
RU2731536C1 |
| SUBSTANCES WITH PREBIOTIC ACTION FOR APPLICATION IN DEODORANTS | 2005 |
|
RU2391091C2 |
| ANHYDROUS POWDER AND LIQUID PARTICLES | 2013 |
|
RU2640184C2 |
